References
- Barnard D B. Extrarenal complications of nephrotic syndrome. Kidney Int 1988; 33: 1184–1202
- Feutern G, Mihatsch M J, For I KBR. Cyclosporin in autoimmune diseases, risk factors for cyclosporin-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654–1660
- Meyrier A, Simon P. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis. Adv Nephrol 1988; 17: 127–150
- Black P, Derfler K, Stockenhuber F, Plassmann S. Cyclosporin therapie bei minial-change-nephritis. Wien Klin Wschr 1987; 99: 242–245
- Frutos M A, Cabello M, Gonzalez-Molina M. Cyclosporin A treatment for nephrotic syndrome secondary to focal segmental glomerulosclerosis. Nephrologia 1988; 8: 136–139
- Berthoux F C, Guerin C, Sabatier J C. Cyclosporin A (Cy A) treatment of steroid-resistant and persistent nephrotic syndrome in primary membranous glomerulonephritis. Nephrol Dial Transplant 1987; 2: 412
- Maher E R, Sweny P, Varghese Z. Sandimmune in treatment of steroid responsive and steroid resistant nephrotic syndrome in adults. Nephrol Dial Transplant 1988; 3: 728–732
- Olsen W, Kindler J, Mihtach M J, Sieberth H G. Long term treatment of minimal-change-nephrotic syndrome with cyclosporin A: a control biopsy study. Nephrol Dial Transplant 1988; 3: 733–737
- Walker R G, Kincaid-Smith P. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal selerosis) with cyclosporin. Nephron 1990; 54: 117–121
- Zietse R, Wenting G J, Kramer P, Mulder P, Schalekamp M A, Weimar W. Contrasting response to cyclosporin in refractory nephrotic syndrome. Clin Nephrol 1989; 31: 22–25
- Luetscher J A, Jr, Deming Q B, Harvey J. Treatment of nephrosis with cortisone. J Clin Invest 1950; 29: 1576–1587
- Pie Y, Cattran D, Delmore T. Evidence suggesting undertreatment in adults with idiopathic focal segmental glomeruloselerosis. Am J Med 1987; 82: 938–944
- Nolasco F, Cameron J S, Heywood E F, Hicks J, Ogg G, Williams D G. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int 1986; 29: 1215–1223
- Meyrier A, Noel L H, Auriche P, Callard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994; 45: 1446–1456
- Niaudet P, Habib R. Cyclosporin in the treatment of idiopathic nephrosis. J Am Soc Nephrol 1994; 5: 1049–1056
- Shalhoub R J. Pathogensis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; 2: 556–560
- Tomizawa S, Nagasawa N, Maruyama N, Shimabukuro H, Arai H, Kurume T. Release of the vascular permeability factor in minimal change nephrotic syndrome is related to CD4+ lymphocytes. Nephron 1990; 56: 341–342
- Jordan S C, Querfeld U, Toyoda M, Prehn J. Serum interleukin-2 levels in a patient with focal segmental glomeruloselerosis. relationship to clinical course and cyclosporin A therapy. Pediatr Nephrol 1990; 4: 166–168
- Tipping P G, Holdsworth S R. Effect of eyclosporin A on antibody-induced experimental glomerulonephritis. Nephron 1985; 40: 201–205